Market Cap

Illumina, Inc. Market Capitalization:

$49.91 Billion

USD as of April 1, 2022

business Illumina, Inc. Company Profile

Illumina, Inc. Main Stock Listing

show_chart NASDAQ: ILMN

Market Capitalization History of Illumina, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Illumina, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2022 $54.05 B 2.77%
Jan. 1, 2021 $52.60 B 12.70%
Jan. 1, 2020 $46.67 B 11.65%
Jan. 1, 2019 $41.80 B 31.11%
Jan. 1, 2018 $31.88 B 74.02%
Jan. 1, 2017 $18.32 B -31.16%
Jan. 1, 2016 $26.62 B 0.79%
Jan. 1, 2015 $26.41 B 68.51%
Jan. 1, 2014 $15.67 B 96.93%
Jan. 1, 2013 $7.96 B 80.97%
Jan. 1, 2012 $4.40 B -51.60%
Jan. 1, 2011 $9.08 B 105.82%
Jan. 1, 2010 $4.41 B 19.46%
Jan. 1, 2009 $3.69 B -12.89%
Jan. 1, 2008 $4.24 B 52.34%
Jan. 1, 2007 $2.78 B 175.51%
Jan. 1, 2006 $1.01 B 51.27%
Jan. 1, 2005 $668.0 M 29.04%
Jan. 1, 2004 $517.7 M 114.08%
Jan. 1, 2003 $241.8 M -71.22%
Jan. 1, 2002 $840.4 M -25.94%
Jan. 1, 2001 $1.13 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

Illumina, Inc. is a biotechnology company specialized in DNA sequencing. It develops, manufactures, and markets genetic and biological analysis systems dedicated to the markets of gene sequencing, genotyping and gene expression, and proteomics. Thanks to its products, Illumina has been able to dramatically reduce the cost of human genome sequencing.

business Illumina, Inc. Company Profile

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.